Purpose As part of the American Association of Physicists in Medicine Working Group on
Stereotactic Body Radiotherapy, tumor control probability (TCP) after stereotactic …

Brain metastases (BMs) represent the most frequent event during the course of Non-Small
Cell Lung Cancer (NSCLC) disease. Recent advancements in the diagnostic and …

The translation of AI-generated brain metastases (BM) segmentation into clinical practice
relies heavily on diverse, high-quality annotated medical imaging datasets. The BraTS …

OBJECTIVE Stereotactic radiosurgery (SRS) is the primary modality for treating brain
metastases. However, effective radiosurgical control of brain metastases≥ 2 cm in …

Purpose Brain metastases (BM) occur frequently in patients with metastatic cancer. Early
and accurate detection of BM is essential for treatment planning and prognosis in radiation …

Stereotactic radiosurgery (SRS) is an established non-invasive ablative therapy for brain
metastases. Early clinical trials with SRS proved that tumor control rates are superior to …

Stereotactic radiosurgery (SRS) is an effective treatment for patients with multiple brain
metastases. Three decades of increasingly powerful scientific studies have shown that SRS …

Background The purpose of this study was to compare the outcomes of patients with non-
small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiotherapy …

OBJECTIVE There are a variety of salvage options available for patients with brain
metastases who experience local failure after stereotactic radiosurgery (SRS). These …

Purpose To evaluate the impact of the distance between treatment isocenter and brain
metastases on local failure in patients treated with a frameless linear-accelerator-based …